Case Study: Leading Life Science Manufacturing Company achieves Day 1 launch readiness weeks ahead of schedule with IntegriChain

Helping Ensure Day 1 Readiness for Launch of Innovative Anti-Psychotic Therapy

Leading Life Science Manufacturing Company, an emerging manufacturer preparing to launch a novel oral anti‑psychotic therapy for an estimated 2.4 million patients, faced significant access and operational challenges—including lack of contract operations back‑office support, complex Government Pricing (GP) compliance, limited retail inventory visibility, and immature gross‑to‑net (GTN) forecasting. To address these risks and ensure Day 1 readiness, they turned to IntegriChain and its Access Platform, including Government Pricing & Rebate Management and GP/GTN advisory services.

IntegriChain implemented its Access Platform and managed services, later adding Channel Aggregation & Inventory Analytics and GTN Accruals & Forecasting, to deliver auditable GP and rebate processing, end‑to‑end pipeline visibility, and automated GTN forecasting. As a result, IntegriChain enabled accurate GTN accruals, timely GP and Medicaid rebate processing, and delivery of critical government contracts weeks in advance—achieving launch readiness weeks ahead of schedule and ensuring Day 1 availability for providers and patients.